The abstract is read at the publisher; the summary is JClub's.
TCDD increases mA enrichment and stabilizes canonical AHR-responsive transcripts in HepG2 cells, and identifies SUV39H2 as a positive regulator of AHR signaling.
- Why it matters: AHR transcription is known, but how RNA mA modifications and chromatin-associated regulators shape AHR responses to TCDD is not fully understood.
- What they did: HepG2 cells were profiled with exploratory MeRIP-seq and matched RNA-seq after vehicle or TCDD treatment, then validated with molecular assays and functional perturbations of SUV39H2.
- The result: SUV39H2 depletion or pharmacological inhibition attenuated TCDD-induced AHR target gene expression and transcriptional activity, while overexpression enhanced responses, and SUV39H2 inhibition reduced AHR-responsive gene induction in mouse liver.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.